Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (241-250 of 539) with videos related to

Pageof 54
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2024
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
NPJ Digital Medicine|May 11, 2026
Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligenceMaximilian Ferle, Jonas Ader, Thomas Wiemers, et al.
European Radiology|July 29, 2015
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI studyMaximilian Merz, Thomas M Moehler, Judith Ritsch, et al.
Cytometry. Part B, Clinical Cytometry|March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myelomaKatharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.
Blood|February 29, 2008
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instabilityTilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, et al.
Radiologie (Heidelberg, Germany)|July 17, 2024
Detection of myeloma-associated osteolytic bone lesions with energy-integrating and photon-counting detector CTMartin Grözinger, Markus Wennmann, Stefan Sawall, et al.
Radiologie (Heidelberg, Germany)|January 13, 2026
Erratum to: Detection of myeloma-associated osteolytic bone lesions with energy-integrating and photon-counting detector CTMartin Grözinger, Markus Wennmann, Stefan Sawall, et al.
Plos One|January 29, 2015
Global myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysisJens Peter Andersen, Martin Bøgsted, Karen Dybkær, et al.
NPJ Digital Medicine|June 16, 2026
Publisher Correction: Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligenceMaximilian Ferle, Jonas Ader, Thomas Wiemers, et al.
Haematologica|March 20, 2025
Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trialSalomon Manier, Meletios-Athanasios Dimopoulos, Xavier P Leleu, et al.
Pageof 54

Showing results (241-250 of 539) with videos related to

Sort By:
Pageof 54
European Journal of Nuclear Medicine and Molecular Imaging|March 8, 2024
Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [<sup>18</sup>F]FDG PET/CT predicts survival in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
NPJ Digital Medicine|May 11, 2026
Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligenceMaximilian Ferle, Jonas Ader, Thomas Wiemers, et al.
European Radiology|July 29, 2015
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI studyMaximilian Merz, Thomas M Moehler, Judith Ritsch, et al.
Cytometry. Part B, Clinical Cytometry|March 27, 2018
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myelomaKatharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, et al.
Blood|February 29, 2008
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instabilityTilmann Bochtler, Ute Hegenbart, Friedrich W Cremer, et al.
Radiologie (Heidelberg, Germany)|July 17, 2024
Detection of myeloma-associated osteolytic bone lesions with energy-integrating and photon-counting detector CTMartin Grözinger, Markus Wennmann, Stefan Sawall, et al.
Radiologie (Heidelberg, Germany)|January 13, 2026
Erratum to: Detection of myeloma-associated osteolytic bone lesions with energy-integrating and photon-counting detector CTMartin Grözinger, Markus Wennmann, Stefan Sawall, et al.
Plos One|January 29, 2015
Global myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysisJens Peter Andersen, Martin Bøgsted, Karen Dybkær, et al.
NPJ Digital Medicine|June 16, 2026
Publisher Correction: Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligenceMaximilian Ferle, Jonas Ader, Thomas Wiemers, et al.
Haematologica|March 20, 2025
Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trialSalomon Manier, Meletios-Athanasios Dimopoulos, Xavier P Leleu, et al.
Pageof 54